{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:44:30Z","timestamp":1791308670817,"version":"4.3.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2012,5,29]]},"DOI":"10.1212\/wnl.0b013e3182583022","type":"journal-article","created":{"date-parts":[[2012,5,17]],"date-time":"2012-05-17T17:20:24Z","timestamp":1337275224000},"page":"1736-1742","source":"Crossref","is-referenced-by-count":105,"title":["Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort"],"prefix":"10.1212","volume":"78","author":[{"given":"A.K.","family":"Trampe","sequence":"first","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hemmelmann","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stroet","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Haghikia","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hellwig","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wiendl","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Goelz","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ziegler","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gold","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chan","sequence":"additional","affiliation":[{"name":"From the Department of Neurology (A.K.T., A.S., A.H., K.H., R.G., A.C.), St. Josef Hospital, Ruhr University, Bochum, Germany; Institut f\u00fcr Medizinische Biometrie und Statistik (C.H., A.Z.), Universit\u00e4t zu L\u00fcbeck, Universit\u00e4tsklinikum Schleswig-Holstein, L\u00fcbeck, Germany; Clinic for Neurology-Inflammatory Disorders of the Central Nervous System and Neurooncology (H.W.), University of M\u00fcnster, M\u00fcnster, Germany; and Elan Pharmaceuticals (S.G.), Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70028-4"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6116-8"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821a446b"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22606"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22304"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22128"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22107"},{"key":"e_1_3_5_9_2","first-page":"113","article-title":"Multiple sclerosis registry in Germany: results of the extension phase 2005\/2006","volume":"105","author":"Flachenecker P","year":"2008","unstructured":"Flachenecker P, Stuke K, Elias W , et al.. Multiple sclerosis registry in Germany: results of the extension phase 2005\/2006. Dtsch Arztebl Int 2008;105:113\u2013119.","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_3_5_10_2","volume-title":"Presented at the 63rd Annual Meeting of the American Academy of Neurology","author":"Sandrock A.","unstructured":"Sandrock A., Hotermans C, Richman S , et al.. Risk stratification for progressive multifocal leukoencephalopathy (PML) in MS patients: role of prior immunosuppressant use, natalizumab-treatment duration, and anti-JCV antibody status. Presented at the 63rd Annual Meeting of the American Academy of Neurology; April 9\u201316, 2011; Honululu, HI."},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511404271"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2011.10.003"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02653.x"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170304"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018506"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e3182583022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:06:50Z","timestamp":1711631210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e3182583022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,29]]},"references-count":14,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2012,5,29]]}},"alternative-id":["10.1212\/WNL.0b013e3182583022"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e3182583022","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,29]]}}}